Literature DB >> 5046776

Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia.

S M Atherden, N D Barnes, D B Grant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5046776      PMCID： PMC1648292          DOI： 10.1136/adc.47.254.602

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  11 in total

1.  DIURNAL VARIATION IN SUPPRESSION OF ADRENAL FUNCTION BY GLUCOCORTICOIDS.

Authors:  T NICHOLS; C A NUGENT; F H TYLER
Journal:  J Clin Endocrinol Metab       Date:  1965-03       Impact factor: 5.958

2.  Diagnosis of congenital adrenal hyperplasia by measurement of plasma 17-hydroxyprogesterone.

Authors:  N D Barnes; S M Atherden
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

3.  Single dose dexamethasone in treatment of congenital adrenocortical hyperplasia.

Authors:  A Hayek; J D Crawford; H H Bode
Journal:  Metabolism       Date:  1971-09       Impact factor: 8.694

4.  Immunoreactive corticotrophin levels in adrenocortical insufficiency.

Authors:  G M Besser; D R Cullen; W J Irvine; J G Ratcliffe; J Landon
Journal:  Br Med J       Date:  1971-02-13

5.  Studies on the deficiency of 21-hydroxylation in patients with congenital adrenal hyperplasia.

Authors:  A P Simpoulos; J R Marshall; C S Delea; F C Bartter
Journal:  J Clin Endocrinol Metab       Date:  1971-03       Impact factor: 5.958

6.  Plasma metyrapone, adrenocorticotropic hormone, cortisol, and deoxycortisol levels. Sequential changes during oral and intravenous metyrapone administration.

Authors:  W Jubiz; S Matsukura; A W Meikle; G Harada; C D West; F H Tyler
Journal:  Arch Intern Med       Date:  1970-03

7.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

8.  The treatment of congenital adrenal hyperplasia with aminoglutethimide.

Authors:  W Hamilton; T Moodie
Journal:  Dev Med Child Neurol       Date:  1970-10       Impact factor: 5.449

9.  Treatment of the nephrotic syndrome in childhood. Use of an alternate-day prednisone regimen.

Authors:  L F Soyka
Journal:  Am J Dis Child       Date:  1967-06

10.  Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia.

Authors:  C A Strott; T Yoshimi; M B Lipsett
Journal:  J Clin Invest       Date:  1969-05       Impact factor: 14.808
View more
  13 in total

1.  Monitoring treatment in congenital adrenal hyperplasia.

Authors:  S Appan; P C Hindmarsh; C G Brook
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

2.  Congenital adrenal hyperplasia: renin and steroid values during treatment.

Authors:  D B Grant; M J Dillon; S M Atherden; R J Levinsky
Journal:  Eur J Pediatr       Date:  1977-08-23       Impact factor: 3.183

Review 3.  Congenital adrenal hyperplasia.

Authors:  G H Newns
Journal:  Arch Dis Child       Date:  1974-01       Impact factor: 3.791

4.  Plasma 17-hydroxyprogesterone in newborn infants with congenital adrenal hyperplasia and in infants with normal adrenal function.

Authors:  S M Atherden; A T Edmunds; D B Grant
Journal:  Arch Dis Child       Date:  1974-03       Impact factor: 3.791

5.  Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.

Authors:  Kyriakie Sarafoglou; John H Himes; Jean M Lacey; Brian C Netzel; Ravinder J Singh; Dietrich Matern
Journal:  Horm Res Paediatr       Date:  2010-08-25       Impact factor: 2.852

6.  Plasma renin activity in the management of congenital adrenal hyperplasia.

Authors:  K D Griffiths; J M Anderson; B T Rudd; N K Virdi; G Holder; P H Rayner
Journal:  Arch Dis Child       Date:  1984-04       Impact factor: 3.791

7.  Duration of suppression of adrenal steroids after glucocorticoid administration.

Authors:  John S Fuqua; Deborah Rotenstein; Peter A Lee
Journal:  Int J Pediatr Endocrinol       Date:  2010-03-31

8.  Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.

Authors:  J Sólyom
Journal:  Arch Dis Child       Date:  1984-08       Impact factor: 3.791

9.  17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.

Authors:  K von Schnakenburg; F Bidlingmaier; D Knorr
Journal:  Eur J Pediatr       Date:  1980-05       Impact factor: 3.183

10.  Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.

Authors:  H Frisch; K Parth; E Schober; W Swoboda
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.